Basics Atyr Pharma, Inc. IPO Date: May 12, 2015 Sector: Healthcare Industry: Biotech Market Cap: $80.73M Activated in VL: True Average Daily Range Avg Daily Range: $0.11 | 3.68% Avg Daily Range (30 D): $0.03 | 3.71% Avg Daily Range (90 D): $0.09 | 4.03% Institutional Daily Volume Avg Daily Volume: .41M Avg Daily Volume (30 D): 2.92M Avg Daily Volume (90 D): 7.94M Trade Size Avg Trade Size (Sh.): 259 Avg Trade Size (Sh.) (30 D): 351 Avg Trade Size (Sh.) (90 D): 358 Institutional Trades Total Inst.Trades: 122 Avg Inst. Trade: $1.71M Avg Inst. Trade (30 D): $.84M Avg Inst. Trade (90 D): $1.15M Avg Inst. Trade Volume: .49M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.67M Avg Closing Trade (30 D): $.84M Avg Closing Trade (90 D): $1.1M Avg Closing Volume: 462.51K     News Dec 6, 2025 @ 5:58 PM ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Inve... Source: Reed Kathrein Dec 6, 2025 @ 1:53 PM ATYR CLASS ACTION DEADLINE ALERT: Bragar Eagel & S... Source: Bragar Eagel & Squire, P.C. Dec 6, 2025 @ 2:38 AM מועד אחרון לת... Source: Rosen Law Firm Dec 5, 2025 @ 10:57 PM ATYR DEADLINE MONDAY: ROSEN, A GLOBALLY RESPECTED ... Source: Rosen Law Firm Dec 5, 2025 @ 5:00 PM ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman Llc Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.26 $-.22 $-.17 Diluted EPS $-.26 $-.22 $-.17 Revenue $ .19M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -25.75M $ -19.53M $ -14.88M Operating Income / Loss $ -26.75M $ -20.31M $ -15.77M Cost of Revenue $ $ $ Net Cash Flow $ -11.24M $ 7.3M $ -1.21M PE Ratio